Met Life Investment Management, LLC Catalyst Pharmaceuticals, Inc. Transaction History

Met Life Investment Management, LLC

  • $18 Billion
  • Q4 2024

A detailed history of Met Life Investment Management, LLC transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 68,087 shares of CPRX stock, worth $1.47 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
68,087
Previous 63,674 6.93%
Holding current value
$1.47 Million
Previous $1.27 Million 12.25%
% of portfolio
0.01%
Previous 0.01%

Shares

61 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025
BUY
$19.73 - $23.93 $87,068 - $105,603
4,413 Added 6.93%
68,087 $1.42 Million
Q3 2024

Nov 13, 2024
SELL
$15.19 - $21.35 $55,640 - $78,205
-3,663 Reduced 5.44%
63,674 $1.27 Million
Q2 2024

Aug 13, 2024
BUY
$14.68 - $16.92 $151,541 - $174,665
10,323 Added 18.11%
67,337 $1.04 Million
Q1 2024

May 14, 2024
BUY
$13.18 - $17.11 $751,444 - $975,509
57,014 New
57,014 $908,000
Q3 2023

May 09, 2024
BUY
$11.69 - $15.02 $20,060 - $25,774
1,716 Added 3.4%
52,200 $610,000
Q2 2023

Apr 29, 2024
BUY
$11.5 - $18.08 $600,300 - $943,775
52,200 New
52,200 $701,000
Q2 2023

Aug 10, 2023
BUY
$11.5 - $18.08 $19,734 - $31,025
1,716 Added 3.4%
52,200 $701,000
Q1 2023

May 09, 2024
BUY
$14.34 - $21.05 $723,940 - $1.06 Million
50,484 New
50,484 $837 Million
Q4 2022

May 10, 2024
SELL
$12.25 - $19.5 $31,972 - $50,895
-2,610 Reduced 4.92%
50,484 $939,000
Q4 2022

Mar 22, 2023
SELL
$12.25 - $19.5 $31,972 - $50,895
-2,610 Reduced 4.92%
50,484 $939,000
Q4 2022

Feb 15, 2023
SELL
$12.25 - $19.5 $31,972 - $50,895
-2,610 Reduced 4.92%
50,484 $939,000
Q3 2022

Jun 14, 2023
BUY
$7.06 - $15.52 $18,426 - $40,507
2,610 Added 5.17%
53,094 $681,000
Q2 2022

May 10, 2024
BUY
$6.23 - $8.57 $23,343 - $32,111
3,747 Added 7.59%
53,094 $372,000
Q2 2022

Jun 20, 2023
BUY
$6.23 - $8.57 $16,260 - $22,367
2,610 Added 5.17%
53,094 $372,000
Q2 2022

Mar 22, 2023
BUY
$6.23 - $8.57 $23,343 - $32,111
3,747 Added 7.59%
53,094 $372,000
Q2 2022

Aug 11, 2022
BUY
$6.23 - $8.57 $23,343 - $32,111
3,747 Added 7.59%
53,094 $372,000
Q1 2022

May 10, 2024
BUY
$5.31 - $8.31 $262,032 - $410,073
49,347 New
49,347 $409,000
Q1 2022

Jun 20, 2023
SELL
$5.31 - $8.31 $6,037 - $9,448
-1,137 Reduced 2.25%
49,347 $409,000
Q1 2022

Mar 22, 2023
BUY
$5.31 - $8.31 $74,430 - $116,481
14,017 Added 39.67%
49,347 $409,000
Q1 2022

May 12, 2022
BUY
$5.31 - $8.31 $74,430 - $116,481
14,017 Added 39.67%
49,347 $409,000
Q4 2021

May 17, 2024
BUY
$5.21 - $7.45 $50,182 - $71,758
9,632 Added 37.48%
35,330 $239,000
Q4 2021

Jun 21, 2023
SELL
$5.21 - $7.45 $78,952 - $112,897
-15,154 Reduced 30.02%
35,330 $239,000
Q4 2021

Mar 22, 2023
BUY
$5.21 - $7.45 $50,182 - $71,758
9,632 Added 37.48%
35,330 $239,000
Q4 2021

Feb 15, 2022
BUY
$5.21 - $7.45 $50,182 - $71,758
9,632 Added 37.48%
35,330 $239,000
Q3 2021

May 17, 2024
SELL
$4.85 - $6.04 $80,131 - $99,792
-16,522 Reduced 39.13%
25,698 $136,000
Q3 2021

Jun 21, 2023
SELL
$4.85 - $6.04 $120,212 - $149,707
-24,786 Reduced 49.1%
25,698 $136,000
Q3 2021

Mar 22, 2023
SELL
$4.85 - $6.04 $80,131 - $99,792
-16,522 Reduced 39.13%
25,698 $136,000
Q3 2021

Nov 15, 2021
SELL
$4.85 - $6.04 $80,131 - $99,792
-16,522 Reduced 39.13%
25,698 $136,000
Q2 2021

Jun 21, 2023
SELL
$4.29 - $6.05 $35,452 - $49,997
-8,264 Reduced 16.37%
42,220 $242,000
Q1 2021

May 17, 2024
SELL
$3.45 - $4.69 $51,039 - $69,383
-14,794 Reduced 25.95%
42,220 $194,000
Q1 2021

Jun 26, 2023
SELL
$3.45 - $4.69 $28,510 - $38,758
-8,264 Reduced 16.37%
42,220 $195 Million
Q1 2021

Mar 22, 2023
BUY
$3.45 - $4.69 $87,809 - $119,369
25,452 Added 151.79%
42,220 $194,000
Q1 2021

May 14, 2021
BUY
$3.45 - $4.69 $87,809 - $119,369
25,452 Added 151.79%
42,220 $195,000
Q4 2020

May 24, 2024
SELL
$2.97 - $3.83 $9,022 - $11,635
-3,038 Reduced 15.34%
16,768 $56,000
Q4 2020

Jun 22, 2023
SELL
$2.97 - $3.83 $100,136 - $129,132
-33,716 Reduced 66.79%
16,768 $56,000
Q4 2020

Mar 22, 2023
SELL
$2.97 - $3.83 $9,022 - $11,635
-3,038 Reduced 15.34%
16,768 $56,000
Q4 2020

Feb 16, 2021
SELL
$2.97 - $3.83 $9,022 - $11,635
-3,038 Reduced 15.34%
16,768 $56,000
Q3 2020

May 24, 2024
SELL
$2.97 - $5.08 $77,222 - $132,085
-26,001 Reduced 56.76%
19,806 $58.8 Million
Q3 2020

Jun 26, 2023
SELL
$2.97 - $5.08 $91,113 - $155,844
-30,678 Reduced 60.77%
19,806 $58,000
Q3 2020

Mar 22, 2023
SELL
$2.97 - $5.08 $77,222 - $132,085
-26,001 Reduced 56.76%
19,806 $58,000
Q3 2020

Nov 13, 2020
SELL
$2.97 - $5.08 $77,222 - $132,085
-26,001 Reduced 56.76%
19,806 $59,000
Q2 2020

May 24, 2024
SELL
$3.48 - $5.05 $39,000 - $56,595
-11,207 Reduced 19.66%
45,807 $212 Million
Q2 2020

Jun 26, 2023
SELL
$3.48 - $5.05 $16,275 - $23,618
-4,677 Reduced 9.26%
45,807 $211,000
Q1 2020

Jul 12, 2023
SELL
$2.61 - $5.21 $12,206 - $24,367
-4,677 Reduced 9.26%
45,807 $176,000
Q1 2020

Mar 22, 2023
BUY
$2.61 - $5.21 $53,491 - $106,778
20,495 Added 80.97%
45,807 $176,000
Q1 2020

May 15, 2020
BUY
$2.61 - $5.21 $53,491 - $106,778
20,495 Added 80.97%
45,807 $176,000
Q4 2019

Jul 12, 2023
SELL
$3.67 - $5.7 $92,381 - $143,480
-25,172 Reduced 49.86%
25,312 $94,000
Q4 2019

Mar 22, 2023
SELL
$3.67 - $5.7 $87,826 - $136,406
-23,931 Reduced 48.6%
25,312 $94,000
Q4 2019

Feb 14, 2020
SELL
$3.67 - $5.7 $87,826 - $136,406
-23,931 Reduced 48.6%
25,312 $95,000
Q3 2019

Jul 12, 2023
SELL
$3.89 - $7.43 $4,827 - $9,220
-1,241 Reduced 2.46%
49,243 $261,000
Q2 2019

Jul 12, 2023
SELL
$2.7 - $6.11 $3,350 - $7,582
-1,241 Reduced 2.46%
49,243 $189,000
Q1 2019

Jul 13, 2023
SELL
$2.11 - $5.33 $2,618 - $6,614
-1,241 Reduced 2.46%
49,243 $251,000
Q4 2018

Jul 13, 2023
SELL
$1.92 - $3.62 $2,382 - $4,492
-1,241 Reduced 2.46%
49,243 $94,000
Q4 2018

Mar 22, 2023
SELL
$1.92 - $3.62 $38,970 - $73,475
-20,297 Reduced 29.19%
49,243 $94,000
Q4 2018

Feb 14, 2019
SELL
$1.92 - $3.62 $38,970 - $73,475
-20,297 Reduced 29.19%
49,243 $95,000
Q3 2018

Jul 13, 2023
SELL
$2.81 - $3.78 $3,487 - $4,690
-1,241 Reduced 2.46%
49,243 $186,000
Q3 2018

Mar 22, 2023
BUY
$2.81 - $3.78 $53,547 - $72,031
19,056 Added 37.75%
69,540 $262,000
Q3 2018

Nov 14, 2018
BUY
$2.81 - $3.78 $53,926 - $72,541
19,191 Added 38.12%
69,540 $263,000
Q2 2018

Aug 15, 2018
BUY
$2.26 - $3.84 $113,788 - $193,340
50,349 New
50,349 $157,000
Q1 2018

May 15, 2018
SELL
$2.39 - $4.01 $88,136 - $147,876
-36,877 Closed
0 $0
Q4 2017

Feb 15, 2018
BUY
$2.51 - $4.4 $92,561 - $162,258
36,877
36,877 $144,000

Others Institutions Holding CPRX

# of Institutions
345
Shares Held
98.4M
Call Options Held
13.4K
Put Options Held
11.7K
View Full List

About CATALYST PHARMACEUTICALS, INC.

CPRX Quotes by TradingView
  • Ticker CPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 102,820,000
  • Market Cap $2.22B
  • Description
  • Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...
More about CPRX
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email